With the mechanistic target of rapamycin (mTOR) signaling pathway enhancing the migration and metastasis of cancer cells, several mTOR inhibitors such as everolimus and temsirolimus are investigated in combinational therapy to treat PC [87,138]. Here, MTOR is linked to cancer.